April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Blue on Yellow Visual Evoked Potentials in Glaucoma
Author Affiliations & Notes
  • Anne C. Herr
    Ophthalmology, RWTH Aachen University, Aachen, Germany
  • Thalia Hirsch
    Ophthalmology, RWTH Aachen University, Aachen, Germany
  • Niklas Plange
    Ophthalmology, RWTH Aachen University, Aachen, Germany
  • Gernot Roessler
    Ophthalmology, RWTH Aachen University, Aachen, Germany
  • Babac Mazinani
    Ophthalmology, RWTH Aachen University, Aachen, Germany
  • Footnotes
    Commercial Relationships  Anne C. Herr, None; Thalia Hirsch, None; Niklas Plange, None; Gernot Roessler, None; Babac Mazinani, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 6087. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Anne C. Herr, Thalia Hirsch, Niklas Plange, Gernot Roessler, Babac Mazinani; Blue on Yellow Visual Evoked Potentials in Glaucoma. Invest. Ophthalmol. Vis. Sci. 2011;52(14):6087.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Previous studies have shown that glaucoma progression can be predicted using blue on yellow visual evoked potentials (byVEP) with stimulation by a Maxwellian view system. Purpose of this study was to test if byVEP results generated by an isoluminant CRT monitor stimulation are able to discriminate glaucoma patients from normals.

Methods: : We examined 53 eyes with glaucoma (20 normal tension glaucoma, 5 PEX-glaucoma, 24 primary open angle glaucoma, 4 pigmentary glaucoma) and 24 healthy eyes. An isoluminant blue-yellow pattern on-off stimulus was presented on a CRT-monitor. A blue checkerboard pattern with a resolution of 2 cycles/degree appeared on an isoluminant yellow background for 200 ms. The stimulus covered the central 40° of the visual field. We evaluated the peak time of the first negative deflection N1.

Results: : The age of glaucoma patients was 67,4 years (range 49 to 84) and 59,7 years (range 38- 80) of healthy subjects (p=0,0091). The mean peak time was 148,4 ± 14,0ms in glaucoma patients and 138,8 +/-13,8ms in normals. This difference was statistically significant (p=0,0064). There was also a statistically significant negative correlation between visual field loss and peaktime of the first negative deflection in glaucomatous eyes (r = -0,34; p=0,013).

Conclusions: : Our results show that byVEP results due to isoluminant monitor stimulation may discriminate between healthy and manifest glaucomatous eyes. Further examinations will have to show whether the detection of early glaucoma or visual field loss progression is possible using this technique.

Keywords: electrophysiology: clinical • visual fields 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×